Qiulian Deng
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 11
- Endocrinology top 5%
- Clinical Biochemistry top 5%
- Pollution top 10%
-
- Pneumonia and Respiratory Infections 14
-
- Streptococcal Infections and Treatments 10
- Neonatal and Maternal Infections 8
-
- Antimicrobial Resistance in Staphylococcus 6
-
- Antibiotics Pharmacokinetics and Efficacy 6
-
- Bacterial Infections and Vaccines 6
-
- Kawasaki Disease and Coronary Complications 4
- Journals
- Hepatology (1 paper)Frontiers in Microbiology (3 papers)FEMS Microbiology Letters (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Qiulian Deng
36 papers receiving 533 citations
Peers
Comparison fields: 5 of 54
- Molecular Medicine 245
- Applied Microbiology and Biotechnology 47
- Endocrinology 111
- Clinical Biochemistry 71
- Pollution 76
Countries citing papers authored by Qiulian Deng
This map shows the geographic impact of Qiulian Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiulian Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiulian Deng more than expected).
Fields of papers citing papers by Qiulian Deng
This network shows the impact of papers produced by Qiulian Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiulian Deng. The network helps show where Qiulian Deng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qiulian Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2023 | 4 | |
| 3 | 2021 | 9 | |
| 4 | 2021 | 4 | |
| 5 | 2021 | 1 | |
| 6 | 2019 | 21 | |
| 7 | 2018 | 28 | |
| 8 | 2018 | 21 | |
| 9 | 2018 | 11 | |
| 10 | 2018 | 36 | |
| 11 | 2018 | 26 | |
| 12 | 2017 | 11 | |
| 13 | 2017 | 1 | |
| 14 | 2016 | 44 | |
| 15 | HCVerso2: a phase III study of faldaprevir plus deleobuvir and ribavirin for chronic HCV genotype 1b infection in treatment naïve patients including those ineligible for pegylated interferon | 2014 | 1 |
| 16 | 2010 | 22 | |
| 17 | 2009 | 36 | |
| 18 | 2008 | 28 | |
| 19 | 2008 | 83 | |
| 20 | 2008 | 53 |
About Qiulian Deng
Qiulian Deng is a scholar working on Molecular Medicine, Microbiology and Endocrinology, having authored 37 papers that have together received 544 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (14 papers), Antibiotic Resistance in Bacteria (11 papers), Streptococcal Infections and Treatments (10 papers), Neonatal and Maternal Infections (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Bacterial Infections and Vaccines (6 papers) and Kawasaki Disease and Coronary Complications (4 papers). The work is most often cited by research in Molecular Medicine (245 citations), Applied Microbiology and Biotechnology (47 citations) and Endocrinology (111 citations). Qiulian Deng has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Huamin Zhong, Chuanqing Wang, Hui Ding, Yonghong Yang, Xuzhuang Shen, Haiying Liu, Quan Lu, Yan Long, Xixi Shen and Aihua Wang. Their work appears in journals such as Hepatology, Frontiers in Microbiology and FEMS Microbiology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.